Fairness opinions › Segments
Medical Transportation fairness opinions
2 public-company healthcare transactions in Medical Transportation, 2011-2017, each with the banker's fairness opinion from the SEC filing: the DCF discount rate and terminal assumptions, the selected companies and precedent transactions, and the deal terms.
Valuation benchmarks
EV / LTM EBITDA
8.1x
median · n=2
EV / LTM revenue
1.58x
median · n=2
DCF discount rate (midpoint)
11.0%
median · n=2
Medical Transportation transactions with a fairness opinion, 2011-2017. Multiples are enterprise value over the last-twelve-months figure disclosed in the filing; the discount rate is the midpoint of the range the banker used in its DCF.
Bankers most often engaged in Medical Transportation
Centerview Partners (1) · RBC Capital Markets (1) · Moelis & Company (1)
All Medical Transportation transactions
| Announced | Target | Acquirer | EV | EV/EBITDA | EV/Rev | DCF rate | Fairness opinion |
|---|---|---|---|---|---|---|---|
| 2017-03-14 | Air Methods | American Securities | $2.5B | 7.6x | 1.96x | 9.5%–10.5% | Centerview Partners |
| 2011-03-28 | Rural/Metro | Warburg Pincus | $658M | 8.6x | 1.20x | 11.5%–12.5% | RBC Capital Markets, Moelis & Company |
3,000+ healthcare deal-level valuation multiples
The Valuation database includes financial details for more than 3,000 healthcare M&A transactions, private and public, with deal-level multiples, categorized by segment, type, and year.